Exane Derivatives Regeneron Pharmaceuticals, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Exane Derivatives holds 2 shares of REGN stock, worth $1,687. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 243
99.18%
Holding current value
$1,687
Previous $169,000
99.41%
% of portfolio
0.0%
Previous 0.05%
Shares
11 transactions
Others Institutions Holding REGN
# of Institutions
1,480Shares Held
85.7MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.59 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.13 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$6.98 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.08 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.91 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $90.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...